(+)-VINCRISTINE
Stage IV Appendix Carcinoma AJCC v8
City of Hope Medical CenterSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Stage IV Appendix Carcinoma AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MITOMYCIN C City of Hope Medical Center | Phase 3 | BB |
Irinotecan City of Hope Medical Center | Phase 1 | CC |
CIS-DIAMMINEDICHLOROPLATINUM II City of Hope Medical Center | Phase 1 | CC |
Inno-206 City of Hope Medical Center | Phase 1 | CC |
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →